Embelin Ameliorates Diethylnitrosamine‐Induced Liver Injury Through Down‐Regulation of Apoptosis, Oxidative Stress and Inflammation by Influencing the Shh/Gli1 Signaling Pathways
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Aydın Akcilar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Experimental Animal Research Center, Kütahya Health Sciences University, Kütahya, Turkey. Hauptthemen laut MEDLINE: Hedgehog Proteins, Benzoquinones, Oxidative Stress, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Diethylnitrosamine (DEN) is a highly toxic compound with teratogenic, mutagenic, and carcinogenic properties. Embelin, a natural benzoquinone derived from Embelia ribes, has shown potential therapeutic effects. This study evaluated embelin's impact on biochemical, histopathological, and gene expression changes in DEN‐induced liver injury. Twenty‐eight male Wistar albino rats were assigned to four groups: Sham, Embelin (E), DEN, and DEN + E. DEN groups received a single intraperitoneal dose of 200 mg/kg DEN, while E and DEN + E groups were administered 1.2 mg/kg embelin for 14 days. Liver enzyme levels, lipid profiles, total antioxidant status (TAS), and total oxidant status (TOS) were measured. RT‐PCR analysis was performed to assess sonic hedgehog ( Shh, Ptch1, Smo, Gli1 ), inflammatory ( TNF‐α, IL‐6, IL‐1β ) and apoptotic ( Tp53, casp3, Bcl‐2, Bax ) gene expression in liver tissue. Histopathological examination showed that DEN induced fibrosis, congestion, apoptosis, and bile pigment accumulation, which were significantly mitigated by embelin. Embelin decreased liver enzyme and lipid levels, increased the activity of TAS, which is an antioxidant capacity, decreased the gene expression levels of pro‐inflammatory cytokines TNF‐α, IL‐6, IL‐1β , and the activation of the Shh signaling pathway. It also increased the expression of Bcl‐2 and decreased the gene expression levels of Tp53, Casp3 , Bax , and inhibited liver apoptosis. These results imply that embelin may have a therapeutic effect on DEN‐induced liver damage by preventing degenerative liver problems, regulating liver functions, suppressing oxidative stress, the inflammatory and apoptotic response, and modulating the Shh signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Experimental Animal Research Center, Kütahya Health Sciences University, Kütahya, Turkey.
- Department of Pathology, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.
- Department of Physiology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Turkey.
ORCID-Profile: Aydın Akcilar, Hikmet Keles, Raziye Akcilar, Fatma Emel Kocak
Zitieren
APA
Akcilar, A., Keles, H., Akcilar, R., & Kocak, F. E. (2025). Embelin Ameliorates Diethylnitrosamine‐Induced Liver Injury Through Down‐Regulation of Apoptosis, Oxidative Stress and Inflammation by Influencing the Shh/Gli1 Signaling Pathways. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70389
Vancouver
Akcilar A, Keles H, Akcilar R, Kocak FE. Embelin Ameliorates Diethylnitrosamine‐Induced Liver Injury Through Down‐Regulation of Apoptosis, Oxidative Stress and Inflammation by Influencing the Shh/Gli1 Signaling Pathways. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70389
BibTeX
@article{Akcilar2025,
author = {Akcilar, Aydın and Keles, Hikmet and Akcilar, Raziye and Kocak, Fatma Emel},
title = {Embelin Ameliorates Diethylnitrosamine‐Induced Liver Injury Through Down‐Regulation of Apoptosis, Oxidative Stress and Inflammation by Influencing the Shh/Gli1 Signaling Pathways},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70389}
}
EUVIMED